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Abstract 
Introduction: Brucellosis is a common zoonotic disease in some areas of the world. It may affect several organs and is known to involve the 
nervous system in 2.7–17.8% of affected patients. During the progression of brucellosis, peripheral neuropathies (PNs) have been reported. 
However, there are few studies investigating the presence of subclinical neuropathy in asymptomatic patients. In our study, we aimed to evaluate 
the presence of peripheral neuropathy using electrophysiological methods in newly-diagnosed untreated brucellosis patients. 
Methodology: The study included a control group of 60 healthy volunteers and 60 untreated brucellosis patients with a positive result of 1/160 
or above on a brucella tube agglutination test. The patient and control groups were evaluated by electrophysiological methods. 
Results: In the patient group, all investigated motor nerves had slower average motor conduction speeds, reduced compound muscle action 
potential (CMAP) amplitudes and delayed F response and terminal latency compared to the control group. The sural nerve sensory conduction 
speed was slower and the sensory nerve action potential (SNAP) was found to be reduced.  
Conclusion: Among the 60 patients with acute brucellosis, 18% had sensorimotor peripheral neuropathy of widespread axonal character. 
Brucellosis can have many effects in the nervous system, including clinical or subclinical peripheral neuropathy in the peripheral nervous 
system. Brucellosis should be considered for differential diagnosis of patients with unexplained neurological and clinically relevant 
electrophysiological findings, especially in regions with endemic brucellosis. 
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Introduction 
Brucellosis is a widespread zoonosis globally. In 
Turkey, especially in Eastern and Southeastern 
Anatolia, brucellosis is frequently encountered as a 
subacute and chronic infection [1]. It is transmitted by 
direct or indirect contact with infected animals. The 
mortality of the disease is low; however, as morbidity 
is high, early diagnosis and treatment is important [2,3]. 
Brucellosis is often seen in regions where animal 
husbandry is common. Due to the wide clinical 
spectrum of brucellosis in humans and the 
heterogeneity of this clinical spectrum, brucellosis 
should be excluded from differential diagnosis where 
risk factors are present [4]. 
Brucellosis affects many organs and systems and 
may present different clinical findings in the central and 
peripheral nervous systems. Studies have demonstrated 
that 4–13% of patients have neurological involvement 
[5,6]. Neurological involvement has been reported in 
both the acute or chronic period of brucellosis. Central 
nervous system involvements of meningitis, 
meningoencephalitis, myelitis, arachnoiditis, brain 
abscess and epidural abscess may be presented [5-7]. 
Peripheral nervous system involvements of 
polyradiculoneuritis, cranial nerve neuropathies and 
peripheral neuropathies have been reported. However, 
only a single study in the literature could be found 
which evaluated the presence of subclinical neuropathy 
in patients asymptomatic for peripheral neuropathies 
[8]. As a result, in Turkey, where brucellosis is 
endemic, we aimed to evaluate the presence of 
subclinical peripheral neuropathies using 
electrophysiology in newly-diagnosed untreated 
brucellosis patients with no clinical or examination 
findings to indicate peripheral neuropathy. 
 
Methodology 
Clinical and demographic characteristics 
This study included a control group of 60 healthy 
volunteers and 60 patients with a clinical diagnosis of 
Sanivar et al. – Peripheral neuropathy in patients with brucellosis     J Infect Dev Ctries 2017; 11(10):753-758. 
754 
brucellosis and from laboratory investigations within 
the Neurology Clinic and the Infectious Disease Clinic 
of Kafkas University Faculty of Medicine in Eastern 
Anatolia from January 2013 to January 2014. The study 
was completed via a case-control approach and this 
study obtained the relevant local hospital ethical 
committee permission (09.01.2013/02/09). All the 
patients gave their written informed consent for 
participation in the study. 
Diagnosis of brucellosis was made after a positive 
(> 1/160 or a 4-fold or greater rise within three weeks) 
standard tube agglutination test (STAT) [1,9] in the 
presence of clinical signs and findings. No patient had 
findings of central nervous system involvement, so 
cerebrospinal fluid investigation was not performed. 
Detailed neurological examinations were 
performed for all participants and tests undertaken 
including full blood counts, formula leukocytes, 
erythrocyte sedimentation rates, C-reactive proteins, 
full urine analysis and biochemical tests (glucose, 
HbA1c, SGOT, SGPT, bilirubin, alkali phosphatase, 
urea, gamma glutamyl transferase, creatinine, vitamin 
B12 and thyroid function tests).  
 All patients were chosen because they were newly 
diagnosed, had not yet received medical treatment for 
brucellosis, had fully normal neurological examination 
results and had no potential diseases that may cause 
peripheral neuropathy.  
As a control group, we included age- and gender-
matched healthy volunteer subjects with no history of 
brucellosis or any other neurological diseases. The tube 
agglutination testing for brucella, as well as all other 
blood tests performed in the patient group, were 
negative or within an expected range for all healthy 
participants.  
The patient and control groups were evaluated by 
electrophysiological methods. Motor conduction 
studies were performed on the unilateral median, ulnar 
and bilateral tibial and peroneal nerves. Sensorial 
conduction studies were performed for the unilateral 
median, ulnar and bilateral sural nerves. F latency was 
also performed for each nerve. 
Nerve conduction was completed as described by 
Preston and Shapiro [10]. During nerve transmission 
measurements using a, (Nihon Kohden,Co., Ltd, 
Tokyo,Japan) EMG-EP electromyography device the 
room temperature was 22 Cº, with body temperature 
kept above 36 Cº. All study participants had their skin 
cleaned with alcohol before the tests to reduce skin 
resistance. Filters set the motor transmission to 10 Hz–
10 kHz, sensory transmission to 20 Hz–2 kHz and F 
latency to 100 Hz–10 kHz. Sensitivity and sweep speed 
for motor transmissions were 1 mV, 5 ms/div; for 
sensory transmission they were 20 μV, 2 ms/div; and 
for F latency they were 200 μV, 100 ms/div. 
Measurements were calculated as the distance 
between the first negative peak and positive peak of 
CMAP amplitude and the distance between negative-
positive peaks of SNAP amplitude. Motor nerve 
transmission speed was obtained by dividing the 
distance between the two stimulation points by the time 
of transmission between the two stimulation points. The 
sensory nerve transmission speed was obtained by 
dividing the distance between the cathode of the 
stimulator electrode and the recording electrode by the 
latency for the same segment. 
Polyneuropathy diagnosis and typing were 
completed taking account of the criteria below. 
- On nerve conduction studies, if the disease of the 
nerve measured progresses with segmental 
demyelinization, motor conduction speed and sensory 
conduction speed fall below 40% of normal and distal 
latency lengthens. CMAP flattens and loses amplitude. 
This slowing, the degree of which changes from nerve 
to nerve, is widespread in all peripheral nerves, mainly 
in the legs combined to the arms, with distal slower 
compared to proximal. Additionally there is clear 
temporal dispersion of CMAP and SNAP. 
- If the disease progresses with axonal degeneration, 
the slowing of motor and sensory conduction are less, 
generally a slowing of less than 30% of normal is 
observed or may be below the lower limit of normal. 
However, there is a clear reduction in CMAP and SNAP 
[11]. 
In our laboratory, reference intervals are used, as 
described by Preston [10]. 
 
Statistical method 
The data obtained in this study were analyzed using 
the SPSS 18.0 (Statistical Package for Social Sciences 
v.18, Chicago, USA) program. Descriptive statistics 
was undertaken including the mean, standard deviation, 
minimum and maximum values, count and percentages. 
The normal distribution and pairwise comparison were 
completed with the t test, three-way comparisons were 
completed using variance analysis for statistics of the 
conductance measurement solutions. The Mann-
Whitney U test and the Kruskall-Wallis test were used 
for non-normal data. For data with normal distribution, 
the Shapiro-Wilk test was used. Significance was 
classed as significant where p < 0.05. 
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Results 
The average age of participants in the patient group 
was 37.90 ± 13.64 years, varying from 18 to 69 years, 
while the average age in the control group was 46.22 ± 
8.98 years varying from 19 to 62 years. When evaluated 
for gender, 55% of participants in the patient group 
were male and 45% were female, while in the control 
group 51.6% were female and 48.3% were male. No 
statistically significant association was found in terms 
of age and gender of patients in comparison to the 
controls. 
The electrophysiological diagnostic criteria for PN 
found that of 60 untreated brucellosis patients, 11 
(18%) were found to have electrophysiological findings 
in accordance with sensorimotor axonal peripheral 
Table 1.The result of the nerve conductance studies of brucellosis patients with peripheral neuropathy. 
 PATIENTS 
 P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 
MEDIAN NERVE MOTOR 
Distal latency(ms) 3.20 3.72 3.24 3.02 2.28 3.51 3.70 3.72 2.80 2.84 3.76 
Velocity(m/s) 52.7 41.1 50.8 62.2 56.0 41.2 53.1 54.0 66.5 57.3 50.8 
Amplitude (mV) 3.6 3.8 2.1 3.7 3.2 7.00 3.0 16.4 5.5 5.58 13.79 
F Latency(ms) 30.5 25.3 26.0 27.4 32.0 31.4 27.4 27.8 28.8 29.8 31.2 
SENSORY            
Velocity (2nd finger-
wrist) ( ms) 
46.1 48.3 39.9 45.4 45.3 none none 40.3 40.3 45.8 45.2 
Amplitude(µV) 4.7 3.0 6.4 2.3 2.8 none none 6.6 5.7 3.2 11.7 
ULNAR NERVE MOTOR 
Distal latency (ms) 3.00 4.3 2.32 2.05 2.66 2.40 2.14 2.26 2.50 2.14 2.40 
Velocity (m/s) 56.1 47.4 53.3 58.1 52.3 52.4 53.4 60.0 63.5 57.2 59.4 
Amplitude (mV) 4.4 4.8 4.4 3.9 6.7 1.7 2.3 5.4 12.6 1.4 4.9 
F Latency (ms) 29.5 25.8 22.8 28.4 28.4 30.1 28.8 26.9 30.2 30.2 30.2 
SENSORY            
Velocity(5th finger-
wrist) (ms) 
45.9 45.1 41.7 44.9 38.0 41.0 45.0 44.5 46.7 46.0 40.2 
Amplitude(µV) 7.8 3.8 5.1 4.2 6.3 1.1 4.6 5.2 4.6 1.0 6.4 
P.TIBIAL NERVE(R) MOTOR 
Distal latency (ms) 6.15 5.55 5.26 3.90 6.05 4.50 6.05 4.05 5.70 6.00 4.85 
Velocity (m/s) 40.3 44.3 41.5 41.4 39.5 49.1 40.4 43.1 45.3 43.3 45.2 
Amplitude (mV) 2.5 3.3 8.6 5.5 1.8 2.8 2.3 7.3 6.3 1.0 5.8 
F Latency (ms) 50.4 50.5 50.5 53.1 50.8 51.9 48.9 52.1 51.2 52.1 50.2 
P.TIBIAL NERVE(L) MOTOR 
Distal latency (ms) 5.3 5.9 6.10 3.65 4.20 4.25 4.50 3.70 6.35 6.50 4.95 
Velocity (m/s) 40.0 48.1 42.0 39.2 39.6 47.3 44.6 43.1 44.1 41.8 46.8 
Amplitude (mV) 1.6 1.4 3.8 3.9 3.4 2.7 8.6 4.9 6.8 1.1 2.79 
F Latency (ms) 53.2 48.5 48.5 53.2 49.9 50.4 51.6 52.1 51.4 48.6 52.4 
PERONEAL NERVE(R)MOTOR 
Distal latency (ms) 6.05 6.65 6.00 6.18 6.75 5.62 6.30 2.25 5.96 4.35 6.20 
Velocity (m/s) 45.7 45.8 46.0 44.2 44.7 43.3 45.6 48.7 40.5 41.1 59.4 
Amplitude (mV) 7.8 1.7 2.1 3.8 1.5 13.9 1.1 4.9 4.7 1.9 0.8 
F Latency (ms) 48.3 50.8 36.0 54.7 46.5 50.2 49.8 54.4 47.6 45.2 52.2 
PERONEAL NERVE(L)MOTOR 
Distal latency (ms) 5.90 5.60 6.30 6.30 5.55 5.03 5.30 2.65 5.50 3.70 5.80 
Velocity (m/s) 46.9 40.8 44.5 40.2 38.3 45.3 44.6 52.4 40.6 46.5 46.2 
Amplitude (mV) 1.8 0.6 1.7 1.2 2.5 2.1 8.0 4.7 6.7 9.2 6.2 
F Latency (ms) 50.0 50.8 46.3 52.1 50.6 50.1 52.5 50.4 50.3 44.1 53.0 
SURAL NERVE(R)            
Velocity (ms) 36.9 44.3 46.1 43.2 42.9 none 41.8 46.4 44.0 none 40.4 
Amplitude (µV) 2.1 1.3 4.8 9.8 2.5 none 6.30 3.7 3.0 none 4.10 
SURAL NERVE(L)            
Velocity (ms) 45.5 48.3 47.0 46.6 45.0 none 31.2 45.9 47.9 none 32.6 
Amplitude (µV) 2.7 2.0 5.2 4.7 1.6 none 2.3 3.8 2.4 none 2.5 
P: patient. 
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neuropathy with more definite involvement of motor 
fibres (Table 1). 
Of patients found to have PN, 6 (54.5%) were male 
and 5 (45.5%) were female. The average age of these 
patients was 46.27 ± 14.85 years (range 22–69 years). 
In the brucellosis patient group, the average age of those 
without peripheral neuropathy was 33.57 ± 12.35 years. 
No statistically significant association was found in 
terms of gender of untreated brucellosis patients with or 
without peripheral neuropathy (p > 0.05) whereas the 
difference in average age was statistically significant. 
The average age of individuals with peripheral 
neuropathy was higher (p < 0.05). 
Comparing the untreated brucellosis patients with 
the control group, the nerve transmission speeds of the 
motor median, ulnar, bilateral peroneal and tibial in the 
patient group were lower than for the control group and 
were statistically significant (p ˂ 0.05). Additionally, 
the terminal latencies of the median and ulnar nerves 
were lengthened compared to controls and there were 
statistically significant (p ˂ 0.05). Also, bilateral 
peroneal and tibial nerve terminal latencies were 
lengthened compared to the control group but no 
statistically significant association was found (p > 
0.05).  
For CMAP amplitudes, the median, ulnar and 
bilateral peroneal were lower than the control group and 
were statistically significant (p ˂ 0,05). 
For sensory transmission studies, while speeds for 
the median, ulnar and bilateral sural were slower in the 
patient group, there was a fall in CSAP for the median, 
ulnar and bilateral sural. 
Similarly in the patient group, F latency lengthened 
for median, ulnar, bilateral peroneal and tibial nerves. 
The results of the nerve conductance studies of patient 
and control groups are shown in Table 2. 
 
Discussion 
There are very few prospective studies researching 
peripheral nervous system involvement of brucella. The 
Table 2. The results of the nerve conductance studies and sociodemographic features of patient and control groups. 
 Patient (n: 60) Control (n: 60) p value U value 
Age 37.90 ± 13.6 46.22 ± 8.98 0,52  
Gender (men/women) 33/27 31/29 0,39  
MEDIAN NERVE MOTOR 
Distal latency (ms) 3.23 ± 0.32 3.17 ± 0.69 0.014 1334.000 
Velocity (m/s) 53.99 ± 4.10 56.61 ± 6.07 ˂ 0.001 1188.000 
Amplitude (mV) 11.71 ± 3.13 15.08 ± 5.26 ˂ 0.001 1037.000 
F Latency (ms) 27.87 ± 2.90 26.16 ± 2.70 0.003 1233.500 
SENSORY     
Velocity (2nd finger-
wrist. m/s) 
43.11 ± 3.40 44.15 ± 10.36 0.518 1677.000 
Amplitude (µV) 13.88 ± 3.92 15.66 ± 6.50 0.011 1315.000 
ULNAR NERVE MOTOR 
Distal latency (ms) 2.92 ± 0.49 2.34 ± 0.51 ˂ 0.001 597.000 
Velocity (m/s) 53.48 ± 5.29 57.61 ± 6.18 ˂ 0.001 T:3.930 
Amplitude (mV) 12.00 ± 2.88 12.75 ± 2.96 0.142 1520.500 
F Latency (ms) 28.28 ± 2.60 26.57 ± 2.36 ˂ 0.001 1114.000 
SENSORY     
Velocity (5th finger-
wrist. m/s) 
42.52 ± 3.00 41.62 ± 4.36 0.263 1587.000 
Amplitude (µV) 12.82 ± 4.52 14.25 ± 5.89 0.150 1525.500 
P.TIBIAL NERVE MOTOR 
Distal latency (ms) 4.55 ± 0.12 4.10 ± 0.06 0.075 272.500 
Velocity (m/s) 43.79 ± 3.49 46.52 ± 2.80 ˂ 0.001 890.000 
Amplitude (mV) 11.60 ± 0.34 12.84 ± 0.39 0.546 1685.000 
F Latency (ms) 50.33 ± 1.67 46.09 ± 2.30 ˂ 0.001 224.500 
PERONEAL NERVE MOTOR 
Distal latency (ms) 4.02 ± 0.13 3.65 ± 0.05 0.381 1633.000 
Velocity (m/s) 45.54 ± 4.77 47.36 ± 3.40 0.018 t: -2.407 
Amplitude (mV) 6.08 ± 0.24 10.45 ± 0.53 ˂ 0.001 472.500 
F Latency (ms) 48.99 ± 4.96 46.16 ± 2.32 ˂ 0.001 648.500 
SURAL NERVE 
Velocity (m/s) 32.41 ± 8.21 35.57 ± 1.96 0.006 1276.500 
Amplitude (µV) 9.00 ± 0.32 11.65 ± 0.29 ˂ 0.001 1052.000 
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majority of information is from case reports. One study 
by Kutlu et al. in 2009 involved 38 brucellosis patients 
and another study by Benbir et al. in 2013 involved 57 
brucellosis and 42 control patients [8,12]. 
The Kutlu et al. study investigated the nerve 
conductance of brucellosis patients before and after 
treatment by electrophysiological approaches by 
examining the motor and sensory transmittance and F 
response of median, ulnar, tibial, peroneal and sural 
nerves using standardized methods and found 
sensorimotor PNs in 35% of the patients [8]. 
In 2013 Benbir et al. researched the presence of PNs 
in brucellosis patients, and similar to our study, found 
sensorial axonal PNP in 19% of the patients with slight 
transmission abnormality in motor and sensory 
branches [12]. 
In addition to these clinical studies, Kaya et al. 
presented a brucellosis patient with macular rash and 
peripheral neuropathy.  Electrophysiological 
investigation of the patient indicated findings 
suggesting a moderate stocking-glove patterns 
demyelinizing sensory peripheral neuropathy.[13]. 
Aygul et al. presented a case with Guillain-Barré 
syndrome (GBS) linked to Brucella spp. infection and 
found nerve transmission blocks, slowing of nerve 
transmission speeds, lengthening of distal latency and 
inability to obtain F response on the 
electrophysiological examination of the patient [14]. 
Shoja et al. presented a nerve conductance study of a 
brucellosis case with renal failure and peripheral 
neuropathy and found symmetric, distal, axonal-type 
sensorimotor peripheral neuropathy especially in the 
lower extremities [15]. Kang et al. in an 
electrophysiological study of a brucellosis patient 
described findings suggesting demyelinizing PNs such 
as lengthened distal latency, reduced nerve 
transmission speed, fall in CMAP amplitudes, delayed 
F response in upper extremities and no F response for 
lower extremities and monitored the patient for a 
diagnosis of chronic inflammatory demyelinizing PN 
linked to brucellosis [16]. 
In our study, the nerve conductance was completed 
unilaterally for upper extremities (on the right) and 
bilaterally for lower extremities. Motor transmission 
speeds slowed in the median and ulnar nerves of the 
upper extremity and terminal latency and delays in F 
latencies lengthened for these nerves. While slowing 
was found only for transmission speeds of motor nerves 
in patients in our study, Kutlu et al. found slowing of 
transmission speeds for both motor and sensory 
branches of median and ulnar nerves in the brucellosis 
group [8]. 
In the whole brucellosis group, the average age of 
those with PN was higher than those without PN (p = 
0.004). Previously Kutlu et al. and Benbir et al. 
described similar studies and found that the patients 
with PN in the brucellosis group had a higher average 
age than the average of the whole brucellosis group and 
stated that the age factor may be a reason for 
identification of PN [8,12]. This fits in with our study 
where the average age of PN patients was higher, 
leading to the consideration that age may create a 
susceptibility for PN. However, the average age of the 
control group without PN (46.22±8.98) is similar to the 
average age of the group with PN (46.27 ± 14.85), 
leading to the consideration that it may not be 
appropriate to link peripheral neuropathy to the age 
factor alone. In the control group, no patient was found 
to have PN.  
While the pathogenesis of peripheral nervous 
system involvement of brucellosis is not fully 
understood, it has been shown that the characteristics of 
Brucella spp. bacteria within cells (phagocytes) may 
damage peripheral nerve cells [5]. Damage to nerves 
during the direct invasion of the Brucella spp. organism 
or production of endotoxins in the acute period may be 
the mechanism for axonal-type peripheral neuropathy 
in peripheral nerves. Immune-modulated mechanisms 
may cause demyelinizing-type peripheral neuropathy 
especially in the chronic period [5,15,17]. Inflammation 
of proximal nerve roots and spinal cord compression 
due to granuloma or abscess may be shown as another 
cause of peripheral neuropathy [3]. A study 
investigating a brucellosis patient with GBS suggested 
that antibodies against gangliosides were responsible 
for the pathogenesis of peripheral nerve involvement. 
This study found that GM1 ganglioside antibodies were 
produced against molecules similar to gangliosides 
expressed on the surface of B.melitensis and caused 
symptoms similar to weakness in extremities and ataxia 
in rats [18]. As a result, it was proposed that 
polyradiculopathies related to brucellosis may cause 
nerve damage due to the antibody response to 
similarities between GM1 ganglioside molecules in 
peripheral nerves and Brucella spp. 
lipooligosaccharides [16,18]. Studies indicate that 
systemic treatment of brucellosis has caused regression 
of peripheral neuropathy linked to Brucella spp. 
infection [8,12]. This shows that though the mechanism 
of peripheral neuropathy linked to Brucella spp. is not 
fully understood, it is reversible via appropriate 
treatment [8].  
In this study, nerve conduction tests in our untreated 
brucellosis patient group identified abnormal findings 
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in comparison to the control group and according to PN 
diagnostic criteria, 18% had axonal PN identified. This 
abnormality may be linked to Brucella spp. infection or 
may be related to other factors. Even with the careful 
selection of the patient and control group, and with the 
exclusion of other known factors that cause PN, 
abnormalities on nerve conduction studies may be 
caused by other unforeseen factors (e.g., genetic 
factors, nutritional habits, medications used, etc.). 
 
Conclusions 
Our electrophysiological investigation discovered 
subclinical, widespread axonal-type PN in patients who 
received a diagnosis of brucellosis, had not started 
medical treatment, had no specific complaints of 
peripheral nervous system involvement and had no 
neurological exam findings. With many different 
involvements of central and peripheral nervous 
systems, brucellosis may be encountered as a cause of 
clinical or subclinical PN; furthermore, PN may regress 
with appropriate brucellosis treatment. As a result, in 
regions where brucellosis is endemic, a differential 
diagnosis should always be considered for PN. 
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